University of Michigan
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Michigan sits in the top decile of US sponsors by registered trial count (#19 of 15,742 sponsors by registered trial count).
University of Michigan: 1,327 sponsored US clinical trials, 179 recruiting.
University of Michigan sponsors 1,327 registered US clinical trials on ClinicalTrials.gov, 179 of them currently recruiting, and 971 completed. 94 of these trials are in Phase 3-4 (later-stage) and 159 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 15 trials.
Top-decile sponsor footprint
University of Michigan ranks in the top decile of sponsors by registered trial count (#19 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
971 of 1,083 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (89.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,327 total, page 4 of 27
YES: Innovative Discussion for Engagement, Achievement, and Service
NCT05337410
Pharmacokinetic Study of Single-Dose Modified Release Glipizide in Healthy Volunteers
NCT05159427
Removing Barriers: Community Partnering for Innovative Solutions to the Opioid Crisis
NCT05665179
Grocery Delivery and Healthy Weight Gain Among Low-income Pregnant Young Women
NCT05000645
Genetic Epidemiology of Rotator Cuff Tears: The cuffGEN Study
NCT04831164
Exercise Effects on Adipose Tissue Structure and Function
NCT04812314
ARDS in Children and ECMO Initiation Strategies Impact on Neurodevelopment (ASCEND)
NCT05388708
The Biomarkers in the Hyperbaric Oxygen Brain Injury Treatment Trial (BioHOBIT)
NCT04855396
Explosive Synchronization of Brain Network Activity in Chronic Pain
NCT04606095
Clinical Trial for Surgery of the Ulnar Nerve (SUN) at the Elbow
NCT04254185
Sleep Behaviors in Pregnancy
NCT04205370
Brain Oxygen Optimization in Severe TBI, Phase 3
NCT03754114
Preliminary Evaluation of a RCMP to Predict Failure of Maxillomandibular Advancement Surgery for OSA
NCT03929549
EDRN Prostate MRI Biomarker Study
NCT03784924
Low FODMAP Plus PEG 3350 for the Treatment of Patients with Irritable Bowel Syndrome-Constipation
NCT03687814
Michigan Contraceptive Access, Research, and Evaluation Study Children: Phase 1
NCT04371900
The LD Lync Study - Natural History Study of Lipodystrophy Syndromes
NCT03087253
Prosthesis Guided Speech Rehabilitation of T1/T2 Cancers of the Tongue
NCT02584270
Short-term Implanted Electrodes Following Regenerative Peripheral Nerve Surgery for Improving Prosthetic Limb Control Signals
NCT03260400
Experimental and Clinical Studies of Retinal Stimulation
NCT03635645
Patient-Centered NeuroRehabilitation (PCN)
NCT03036319
Cardiovascular Health Improvement Project
NCT02306200
The Role of Antibiotics in Full Thickness Skin Graft Survival for Facial Reconstructive Surgery
NCT01912651
Laser-based Photoacoustic Tomography of Human Inflammatory Arthritis
NCT00748254
Bicuspid Aortic Valve (BAV) Registry
NCT01756222
Nephrotic Syndrome Study Network
NCT01209000
Identification of Phenotypic Factors That Predict Success for Weight Loss and Long-term Weight Maintenance
NCT02043457
Clinical Phenotyping Resource and Biobank Core of the Michigan O'Brien Renal Center
NCT01016613
University of Michigan "Nephrology Research BioBank"
NCT00381121
Implementation Guided by aN Iterative, adapTivE Strategy - Induction of Labor
NCT07547657
Feasibility and Acceptability of Peer Intervention for Improving Mental Health Among People Accessing Hormone Care
NCT07354113
A Tailored, Web-Based Self-Management Program to Treat Pain in Chronic Pancreatitis
NCT07223554
A Multi-component, Person-centered, and Yoga-based Coaching Program for Lupus Chronic Pain
NCT07196072
Health Impact 360: Advancing Physical, Social, and Mental Health Among Marginalized Communities for Cardiovascular Health Equity
NCT07034352
Mobile Application for Patient Engagement and Physician-Directed Remote Management of Heart Failure
NCT06750549
Social Prescribing and Relationship Cognitive Strategies (SPARCS)
NCT06656975
Intern Health Study 2024
NCT06465680
Precision Feedback to Improve Health Care Quality
NCT05923463
Michigan Emergency Department Improvement Collaborative (MEDIC) Alert; Pulmonary Embolism (PE)
NCT06312332
Evaluating a School-based Social and Material Needs Identification System to Prevent Youth Violence Involvement
NCT05986188
Pregnancy and Contraception Education in Chronic Kidney Disease (PACE-CKD)
NCT06189807
Brief Interventions in Chronic Migraine
NCT05979337
The Inspiring Action to Prevent Diabetes Intervention
NCT06001801
Evaluation of Safety and Efficiency of Metreleptin Treatment for Patients With Multiple Symmetric Lipomatosis (MSL)
NCT05351164
LiveSMART Trial to Prevent Falls in Patients With Cirrhosis - Supplementary Study
NCT07140120
My Best GI Eating Study
NCT05396846
Evaluation of Patient Coach Support for Older Adults With Obesity
NCT06624163
A Trial of a Positive Psychology Intervention for Older Adults (RESET)
NCT05451589
Home Exercise And Resiliency Training (Heart) Club
NCT05543733
Behavioral Change Following Alzheimer's Disease (AD) Biomarker Disclosure
NCT05584241
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 79 |
| Phase 2 | 80 |
| Phase 3 | 25 |
| Phase 4 | 69 |
Therapeutic Areas
What is open in the University of Michigan pipeline
179 recruiting of 1,327 indexed (13% open); 971 completed (73%).
Phase mix: 94 late (III/IV) vs 159 early (I/II) (early-phase heavy).
Top condition: Depression (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Michigan: open-pipeline peers nationwide
Peers matched on 1,327 registered trials and 13% open enrollment, not the therapeutic-area sidebar.
University of Michigan sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,327 trials (± recruiting share)
- Eli Lilly and Company · 1,341 trials · 9% recruiting
- GlaxoSmithKline · 1,345 trials · 4% recruiting
- AstraZeneca · 1,285 trials · 12% recruiting
- University of Colorado, Denver · 1,283 trials · 21% recruiting
Sponsors near 13% open enrollment (± trial volume)
- Wayne State University · 13% recruiting · 163 trials
- Case Comprehensive Cancer Center · 14% recruiting · 407 trials
- Albany Medical College · 13% recruiting · 52 trials
- Taiho Oncology · 13% recruiting · 52 trials
Related
What to do with this University of Michigan page
1,327 registered trials is a research-attention snapshot, not an endorsement of University of Michigan or any single study.
- 179 of University of Michigan's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Depression is the condition University of Michigan studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Michigan pipeline card: 1,327 registered trials from official public datasets.Report a data error.